Celcuity Inc.
CELC
$10.64
$0.666.61%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/7/2025
-
Tickeron - Technical Analysis
3/7/2025
-
Tickeron - Stocks
3/5/2025
-
ETF Channel
3/5/2025
-
Tickeron - Stocks
3/4/2025
-
Stock Options Channel
2/27/2025
-
CNW Group - News Releases
2/27/2025
-
PR Newswire
2/26/2025
-
Tickeron - Stocks
2/26/2025
-
Tickeron - Stocks
2/25/2025
-
GuruFocus
2/25/2025
-
Globe Newswire
2/19/2025
-
Seeking Alpha - Long Ideas
2/19/2025
-
SeekingAlpha
2/19/2025
-
MarketBeat
2/15/2025
-
GuruFocus
2/15/2025
-
GuruFocus
2/13/2025
-
Tickeron - Stocks
2/10/2025
-
MarketBeat
2/8/2025
-
MarketBeat
2/8/2025
-
Tickeron - Stocks
2/7/2025
-
MarketBeat
2/6/2025
-
TipRanks Financial Blog
2/6/2025
-
The Fly
2/4/2025
-
GuruFocus
2/4/2025
-
Tickeron - Stocks
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, November 14, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Mar 24 and 28 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
763 392 0767
Address
16305–36th Avenue North
Minneapolis, MN 55446
Minneapolis, MN 55446
Country
Year Founded
Business Description
Sector
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company’s CELsignia...
more
